Company intelligence

ENTA

Enanta Pharmaceuticals, Inc. · NASDAQ · Healthcare

Price$14.15+0.50% · +$0.07

Market cap411.46MEquity value

P / E-5.9Trailing ratio

Volume0Latest session

Market data

ENTA price chart

TradingView

Related signals

1 min delayed

Browse public ENTA signals with their source context and measured market impact. Open any signal for its permanent analysis page.

ENTAMay 6, 2024-10.27% since signal

Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates

- Enanta Pharmaceuticals reported a quarterly loss of $1.47 per share, surpassing loss estimates. - Revenues for the quarter were $17.05 million, beating expectations by 3.55%. - Company's stock has gained 61.2% year-to-date, outperforming the S&P 500. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings

View signal analysis

Research